Immunology

Items 31-40 of 127

per page
Set Descending Direction
  1. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper
  2. Fc (human):Dectin-1 (mouse) (rec.)
    AG-40B-0138
    AG-40B-0138-C05050 µg
    CHF 350.00
  3. Fc (human):Dectin-2 (mouse) (rec.)
    AG-40B-0139
    AG-40B-0139-C05050 µg
    CHF 350.00
  4. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  5. Fc (human):FGL1 (mouse) (rec.)
    AG-40B-0185
    AG-40B-0185-C01010 µg
    CHF 240.00
    AG-40B-0185-30103 x 10 µg
    CHF 480.00
    AG-40B-0185-C100100 µg
    CHF 1'140.00
  6. Fc (human):FLT3 Ligand (human) (rec.)
    AG-40B-0119
    AG-40B-0119-C01010 µg
    CHF 240.00
    AG-40B-0119-30103 x 10 µg
    CHF 480.00
    AG-40B-0119-C100100 µg
    CHF 960.00
    Influence of FLT3L treatment on lymphocyte subpopulations. Method: C57BL/6 mice were injected intraperitoneally with 10 μg daily or were left untreated. (A) Percentages of indicated splenic subpopulations in FLT3L KO, WT control or WT-treated mice.
  7. Fc (human):RANKL, Soluble (mouse) (rec.)
    AG-40B-0059
    AG-40B-0059-C01010 µg
    CHF 265.00
  8. Fc (LAEA-PG)-KIH (mouse) IgG2b Control (rec.)
    AG-35B-0019
    AG-35B-0019-C05050 µg
    CHF 340.00
    NEW Fc (LAEA-PG)-KIH (mouse) IgG2b Control (rec.)
  9. Fc (LALA-PG)-KIH (human) IgG1 Control (rec.)
    AG-35B-0018
    AG-35B-0018-C05050 µg
    CHF 340.00
    Fc (LALA-PG)-KIH (human) IgG1 Control (rec.)
  10. Fc (LALA-PG)-KIH (human):GDF15 (human) (rec.)
    AG-40B-0253
    AG-40B-0253-C05050 µg
    CHF 440.00
    NEW Fc (LALA-PG)-KIH (human):GDF15 (human) (rec.)

Items 31-40 of 127

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.